ID25776A - Hidrohalogenida-hidrohalogenida 1'-(-4-(1-(4-flourofenil)-1-h-indola-3-il)-1-butil)-spiro (isobenzofuran-1(3h),4-piperidin - Google Patents

Hidrohalogenida-hidrohalogenida 1'-(-4-(1-(4-flourofenil)-1-h-indola-3-il)-1-butil)-spiro (isobenzofuran-1(3h),4-piperidin

Info

Publication number: ID25776A
Authority: ID; Indonesia
Prior art keywords: hydrohalogenides; flourofenil; indola; butil; isobenzofuran
Prior art date: 1997-11-07

Application number

IDW20000997D

Other languages

English (en)

Inventor

Niels Mork

Heidi Lopez De Diego

Ole Nielsen

Original Assignee

Lundbeck & Co As H

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-11-07

Filing date

1998-11-06

Publication date

2000-11-02

1998-11-06 Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H

2000-11-02 Publication of ID25776A publication Critical patent/ID25776A/id

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Veterinary Medicine (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Psychiatry (AREA)
Psychology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Hospice & Palliative Care (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

IDW20000997D 1997-11-07 1998-11-06 Hidrohalogenida-hidrohalogenida 1'-(-4-(1-(4-flourofenil)-1-h-indola-3-il)-1-butil)-spiro (isobenzofuran-1(3h),4-piperidin ID25776A (id)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DK126797		1997-11-07

Publications (1)

Publication Number	Publication Date
ID25776A true ID25776A (id)	2000-11-02

Family

ID=8102935

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW20000997D ID25776A (id)	1997-11-07	1998-11-06	Hidrohalogenida-hidrohalogenida 1'-(-4-(1-(4-flourofenil)-1-h-indola-3-il)-1-butil)-spiro (isobenzofuran-1(3h),4-piperidin

Country Status (39)

Country	Link
US (2)	US6844352B2 (id)
EP (1)	EP1044202B1 (id)
JP (1)	JP3605358B2 (id)
KR (1)	KR100399274B1 (id)
CN (1)	CN1105115C (id)
AR (1)	AR023010A1 (id)
AT (1)	ATE288918T1 (id)
AU (1)	AU749094B2 (id)
BG (1)	BG64906B1 (id)
BR (1)	BR9813949A (id)
CA (1)	CA2308745C (id)
CZ (1)	CZ288666B6 (id)
DE (1)	DE69828999T2 (id)
DZ (1)	DZ2642A1 (id)
EA (1)	EA002092B1 (id)
EG (1)	EG23791A (id)
ES (1)	ES2234162T3 (id)
HK (1)	HK1034075A1 (id)
HR (1)	HRP20000261B1 (id)
HU (1)	HUP0100991A3 (id)
ID (1)	ID25776A (id)
IL (1)	IL135723A (id)
IS (1)	IS2342B (id)
JO (1)	JO2052B1 (id)
MA (1)	MA25585A1 (id)
NO (1)	NO325920B1 (id)
NZ (1)	NZ504065A (id)
PE (1)	PE130299A1 (id)
PL (1)	PL190538B1 (id)
PT (1)	PT1044202E (id)
RS (1)	RS49777B (id)
SK (1)	SK285245B6 (id)
TN (1)	TNSN98201A1 (id)
TR (1)	TR200001267T2 (id)
TW (1)	TW483894B (id)
UA (1)	UA64769C2 (id)
UY (1)	UY25236A1 (id)
WO (1)	WO1999024436A1 (id)
ZA (1)	ZA9810116B (id)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR030453A1 (es) *	2000-08-15	2003-08-20	Lundbeck & Co As H	Composicion farmaceutica con contenido de 1' [4-[1-(4-fluorofenil)-1h-indol-3-il]-1-butil] espiro [isobenzofuran-1 (3h), 4'-piperidina]
AU2003263155A1 (en) *	2002-09-20	2004-04-08	H. Lundbeck A/S	Method for manufacture of dihydroisobenzofuran derivatives
US7863272B2 (en)	2003-06-12	2011-01-04	M's Science Corporation	Sigma ligands for neuronal regeneration and functional recovery
US20090306341A1 (en) *	2005-07-29	2009-12-10	Joachim Emmert	LC/MS Blends Containing Ionizing Additives
WO2007047978A2 (en)	2005-10-21	2007-04-26	Braincells, Inc.	Modulation of neurogenesis by pde inhibition
EP2314289A1 (en)	2005-10-31	2011-04-27	Braincells, Inc.	Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) *	2006-03-08	2010-08-26	Braincells, Inc.	Modulation of neurogenesis by nootropic agents
US20070244143A1 (en) *	2006-03-08	2007-10-18	Braincells, Inc	Modulation of neurogenesis by nootropic agents
US20100009983A1 (en) *	2006-05-09	2010-01-14	Braincells, Inc.	5 ht receptor mediated neurogenesis
CA2651813A1 (en)	2006-05-09	2007-11-22	Braincells, Inc.	Neurogenesis by modulating angiotensin
US7678808B2 (en) *	2006-05-09	2010-03-16	Braincells, Inc.	5 HT receptor mediated neurogenesis
EP2068872A1 (en) *	2006-09-08	2009-06-17	Braincells, Inc.	Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en)	2006-09-19	2010-07-22	Braincells, Inc.	Modulation of neurogenesis by ppar agents
CA2663347A1 (en) *	2006-09-19	2008-03-27	Braincells, Inc.	Ppar mediated modulation of neurogenesis
WO2010099217A1 (en)	2009-02-25	2010-09-02	Braincells, Inc.	Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5109002A (en) *	1989-09-08	1992-04-28	Du Pont Merck Pharmaceutical Company	Antipsychotic 1-cycloalkylpiperidines
NZ243065A (en) *	1991-06-13	1995-07-26	Lundbeck & Co As H	Piperidine derivatives and pharmaceutical compositions

1998
- 1998-06-11 UA UA2000052828A patent/UA64769C2/uk unknown
- 1998-10-20 TW TW087117299A patent/TW483894B/zh not_active IP Right Cessation
- 1998-10-27 MA MA25316A patent/MA25585A1/fr unknown
- 1998-11-03 EG EG136298A patent/EG23791A/xx active
- 1998-11-04 TN TNTNSN98201A patent/TNSN98201A1/fr unknown
- 1998-11-04 DZ DZ980252A patent/DZ2642A1/xx active
- 1998-11-05 ZA ZA9810116A patent/ZA9810116B/xx unknown
- 1998-11-05 JO JO19982052A patent/JO2052B1/en active
- 1998-11-05 PE PE1998001067A patent/PE130299A1/es not_active Application Discontinuation
- 1998-11-05 AR ARP980105596A patent/AR023010A1/es active IP Right Grant
- 1998-11-06 RS YUP-235/00A patent/RS49777B/sr unknown
- 1998-11-06 KR KR10-2000-7004858A patent/KR100399274B1/ko not_active IP Right Cessation
- 1998-11-06 NZ NZ504065A patent/NZ504065A/en unknown
- 1998-11-06 WO PCT/DK1998/000480 patent/WO1999024436A1/en active IP Right Grant
- 1998-11-06 DE DE69828999T patent/DE69828999T2/de not_active Expired - Fee Related
- 1998-11-06 CN CN98810910A patent/CN1105115C/zh not_active Expired - Fee Related
- 1998-11-06 CZ CZ20001663A patent/CZ288666B6/cs not_active IP Right Cessation
- 1998-11-06 PT PT98952580T patent/PT1044202E/pt unknown
- 1998-11-06 CA CA002308745A patent/CA2308745C/en not_active Expired - Fee Related
- 1998-11-06 JP JP2000520446A patent/JP3605358B2/ja not_active Expired - Fee Related
- 1998-11-06 AT AT98952580T patent/ATE288918T1/de not_active IP Right Cessation
- 1998-11-06 HU HU0100991A patent/HUP0100991A3/hu unknown
- 1998-11-06 IL IL13572398A patent/IL135723A/xx not_active IP Right Cessation
- 1998-11-06 EP EP98952580A patent/EP1044202B1/en not_active Expired - Lifetime
- 1998-11-06 BR BR9813949-5A patent/BR9813949A/pt not_active Application Discontinuation
- 1998-11-06 ID IDW20000997D patent/ID25776A/id unknown
- 1998-11-06 EA EA200000502A patent/EA002092B1/ru not_active IP Right Cessation
- 1998-11-06 UY UY25236A patent/UY25236A1/es not_active IP Right Cessation
- 1998-11-06 TR TR2000/01267T patent/TR200001267T2/xx unknown
- 1998-11-06 AU AU10226/99A patent/AU749094B2/en not_active Ceased
- 1998-11-06 SK SK646-2000A patent/SK285245B6/sk not_active IP Right Cessation
- 1998-11-06 ES ES98952580T patent/ES2234162T3/es not_active Expired - Lifetime
- 1998-11-06 PL PL98340220A patent/PL190538B1/pl not_active IP Right Cessation
2000
- 2000-04-18 IS IS5460A patent/IS2342B/is unknown
- 2000-04-27 NO NO20002188A patent/NO325920B1/no not_active IP Right Cessation
- 2000-05-04 HR HR20000261A patent/HRP20000261B1/xx not_active IP Right Cessation
- 2000-05-29 BG BG104485A patent/BG64906B1/bg unknown
2001
- 2001-06-28 HK HK01104490A patent/HK1034075A1/xx not_active IP Right Cessation
2002
- 2002-10-15 US US10/272,403 patent/US6844352B2/en not_active Expired - Fee Related
2004
- 2004-12-13 US US11/012,084 patent/US20050171135A1/en not_active Abandoned

Also Published As

Publication number	Publication date
ES2234162T3 (es)	2005-06-16
EA200000502A1 (ru)	2000-10-30
IS2342B (is)	2008-02-15
CZ288666B6 (cs)	2001-08-15
NO20002188L (no)	2000-06-14
BG104485A (en)	2001-01-31
SK6462000A3 (en)	2000-10-09
DE69828999D1 (de)	2005-03-17
IL135723A0 (en)	2001-05-20
JP3605358B2 (ja)	2004-12-22
PL340220A1 (en)	2001-01-15
HRP20000261B1 (en)	2009-04-30
EG23791A (en)	2007-08-13
CA2308745A1 (en)	1999-05-20
NO325920B1 (no)	2008-08-18
CN1105115C (zh)	2003-04-09
PT1044202E (pt)	2005-04-29
AU1022699A (en)	1999-05-31
HUP0100991A3 (en)	2003-03-28
CN1278823A (zh)	2001-01-03
HRP20000261A2 (en)	2001-04-30
PL190538B1 (pl)	2005-12-30
NO20002188D0 (no)	2000-04-27
AU749094B2 (en)	2002-06-20
TR200001267T2 (tr)	2000-09-21
CZ20001663A3 (cs)	2000-10-11
HK1034075A1 (en)	2001-10-12
US20050171135A1 (en)	2005-08-04
NZ504065A (en)	2002-05-31
RS49777B (sr)	2008-06-05
AR023010A1 (es)	2002-09-04
ZA9810116B (en)	1999-05-07
EP1044202A1 (en)	2000-10-18
TW483894B (en)	2002-04-21
TNSN98201A1 (fr)	2005-03-15
KR100399274B1 (ko)	2003-09-26
BG64906B1 (bg)	2006-08-31
JP2001522852A (ja)	2001-11-20
IL135723A (en)	2005-11-20
JO2052B1 (en)	1999-05-15
US20030055074A1 (en)	2003-03-20
EP1044202B1 (en)	2005-02-09
BR9813949A (pt)	2000-09-26
UA64769C2 (uk)	2004-03-15
EA002092B1 (ru)	2001-12-24
US6844352B2 (en)	2005-01-18
YU23500A (sh)	2003-12-31
DZ2642A1 (fr)	2004-12-28
KR20010031791A (ko)	2001-04-16
PE130299A1 (es)	1999-12-16
IS5460A (is)	2000-04-18
CA2308745C (en)	2004-01-20
ATE288918T1 (de)	2005-02-15
WO1999024436A1 (en)	1999-05-20
HUP0100991A2 (hu)	2001-09-28
DE69828999T2 (de)	2005-07-21
MA25585A1 (fr)	2002-12-31
UY25236A1 (es)	2000-12-29
SK285245B6 (sk)	2006-09-07

Publication	Publication Date	Title
GB9808800D0 (en)	1998-06-24	Well logging instruments
DE69609006D1 (de)	2000-08-03	Tintenstrahldrucktinten
DE59606460D1 (de)	2001-03-29	Bohrstange
ATE202105T1 (de)	2001-06-15	8-substituierte-1,3,8-triazaspiro(4,5)decan-4- onderivate
EP0843984A4 (en)	1999-10-13	BIDET
ID25776A (id)	2000-11-02	Hidrohalogenida-hidrohalogenida 1'-(-4-(1-(4-flourofenil)-1-h-indola-3-il)-1-butil)-spiro (isobenzofuran-1(3h),4-piperidin
ATE212635T1 (de)	2002-02-15	1,3,8-triazaspiro(4,5)decan-4-on-derivate
DE69622234D1 (de)	2002-08-14	Tintenstrahldrucker
ATE204279T1 (de)	2001-09-15	Diaza-spiro(3,5)nonan-derivate
GB2300145B (en)	1997-04-16	Compass saw
DE69617465D1 (de)	2002-01-10	Printer
SG70655A1 (en)	2000-02-22	New spirocyclic compounds
GB2302295B (en)	1999-03-10	Reamer
GB9501694D0 (en)	1995-03-15	Stepped tapered leader
GB2311736B (en)	1999-12-08	Ultra-violet (u.v) bubble mix
AU5300398A (en)	1998-08-13	Guide post driver
SI1044202T1 (en)	2005-04-30	1'- 4- 1- (4-fluorophenyl)- 1h-indole-3-yl) -1-butyl)-spiro isobenzofuran- 1(3h),4'- piperidine) hydrohalogenides
AU6870896A (en)	1997-03-12	Substituted quinazolin(thi)ones
AU717385C (en)	2002-09-19	Guide post
GB9517373D0 (en)	1995-10-25	Reamer
TW302604U (en)	1997-04-11	Combination type potting set
GB9526734D0 (en)	1996-02-28	Drill levelling device
KR970008471U (ko)	1997-03-27	잉크보충식 마카펜
KR960036642U (ko)	1996-12-16	잉크보충식 마카펜
FI951093A0 (fi)	1995-03-08	Spolanordning foer WC